Contineum Therapeutics CTNM
NASDAQ CTNM
$8.72 +0.26 (+3.01%)
As of: Oct 21, 2026 · 2:14 PM EDT

Contineum Therapeutics (CTNM) Other financing activities (2024 - 2026)

Updated

Analysis

Contineum Therapeutics (CTNM) Other financing activities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn
10 Contineum Therapeutics 328.22 Mn -599.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53,000.00
Mar 31, 2026 -69,000.00
Sep 30, 2025 -80,000.00
Jun 30, 2025 -176,000.00
Jun 30, 2024 140,000.00
Mar 31, 2024 -140,000.00
API Access

Contineum Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CTNM&period=max&api_key=YOUR_API_KEY